YWYingpeng Wan

Yingpeng Wan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yingpeng Wan has a total of 144 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Topological Engineering of NIR‐II Emissive Conjugated Oligomers With Unexpected Excited‐State Manifolds for Efficient Phototheranostics and Cancer Immunotherapy

    by Yuliang Yang, Yijian Gao, Ning Li, Yingpeng Wan, Huan Chen, Jie Zhang, Cui Cen, Yafeng Zhou, Shengliang Li

    Phototheranostic agents operating in the second near‐infrared (NIR‐II) window hold great potential for precision cancer therapy, yet the rational regulation of excited‐state processes to simultaneously optimize fluorescence and phototherapeutic performances remains a fundamental challenge. Herein, we report a topology‐driven excited‐state engineering strategy for constructing conjugated oligomers with tailored excited‐state manifolds and multi‐channel excitation dynamics. By precisely manipulating molecular topology, conjugated topological oligomers achieve enhanced light‐harvesting capability and optimized exciton utilization, thereby enabling synergistic regulation of excitation dynamics. Under 808 nm laser irradiation, nanoparticles (NPs) derived from TBT‐3 exhibit 2.8‐fold enhanced NIR‐II fluorescence brightness, 2.7‐fold improved photothermal performance, and 7.5‐fold increased total reactive oxygen species (ROS) generation compared with TBT‐1. In vivo studies demonstrate that TBT‐3 NPs enable high‐resolution NIR‐II fluorescence imaging and efficient tumor elimination. Moreover, TBT‐3‐mediated phototherapy induces immunogenic cell death and enhances antitumor immunity, leading to improved therapeutic efficacy when combined with anti‐PD‐1 immune checkpoint blockade. This work provides a molecular topology‐based strategy for manipulating excited‐state landscapes and establishes conjugated oligomers as versatile candidates for NIR‐II phototheranostics and cancer immunotherapy.

  • Topological Engineering of NIR‐II Emissive Conjugated Oligomers With Unexpected Excited‐State Manifolds for Efficient Phototheranostics and Cancer Immunotherapy

    by Yuliang Yang, Yijian Gao, Ning Li, Yingpeng Wan, Huan Chen, Jie Zhang, Cui Cen, Yafeng Zhou, Shengliang Li

    Phototheranostic agents operating in the second near‐infrared (NIR‐II) window hold great potential for precision cancer therapy, yet the rational regulation of excited‐state processes to simultaneously optimize fluorescence and phototherapeutic performances remains a fundamental challenge. Herein, we report a topology‐driven excited‐state engineering strategy for constructing conjugated oligomers with tailored excited‐state manifolds and multi‐channel excitation dynamics. By precisely manipulating molecular topology, conjugated topological oligomers achieve enhanced light‐harvesting capability and optimized exciton utilization, thereby enabling synergistic regulation of excitation dynamics. Under 808 nm laser irradiation, nanoparticles (NPs) derived from TBT‐3 exhibit 2.8‐fold enhanced NIR‐II fluorescence brightness, 2.7‐fold improved photothermal performance, and 7.5‐fold increased total reactive oxygen species (ROS) generation compared with TBT‐1. In vivo studies demonstrate that TBT‐3 NPs enable high‐resolution NIR‐II fluorescence imaging and efficient tumor elimination. Moreover, TBT‐3‐mediated phototherapy induces immunogenic cell death and enhances antitumor immunity, leading to improved therapeutic efficacy when combined with anti‐PD‐1 immune checkpoint blockade. This work provides a molecular topology‐based strategy for manipulating excited‐state landscapes and establishes conjugated oligomers as versatile candidates for NIR‐II phototheranostics and cancer immunotherapy.

  • Open Access

    Decoupling Optical Functions via Ratio-Tunable Conjugated Copolymers with Hydrogen-Bond-Enforced Rigidity for Quenching-Resistant NIR-II Phototheranostics

    by Weilong Chen, Chuang Zhang, Guan-Lin Wu, Ka-Wai Lee, Zhiqiang Guan, Yujuan Li, Bo-De Chen, Chao Zhao, Yung-Kang Peng, Jinfeng Zhang, et al.

    Organic near-infrared II (NIR-II) phototheranostic agents hold great promise for tumor imaging and phototherapy. However, their development is fundamentally challenged by the coupled and competing optical pathways in conventional designs: rigid planar fluorophores that excel in the molecular state often suffer from severe aggregation-caused quenching (ACQ) in nanoparticles, leading to drastic losses in both fluorescence and reactive oxygen species (ROS) generation. To decouple these optical functions, we report a modular copolymer-based anti-quenching strategy by integrating a flexible segment with a hydrogen-bond-enforced rigid segment. The key to decoupling lies in the tunable segment ratio, which allows composition-dependent modulation with reduced trade-offs of NIR-II fluorescence, ROS production, and photothermal conversion. As the rigid-segment fraction increases in the copolymer series (F8R2, F5R5, and F2R8), NIR-II fluorescence and ROS generation are markedly enhanced, while the photothermal conversion efficiency is only slightly compromised. Remarkably, the F2R8 nanoparticles (80% rigid segment) retain >60% of their NIR-II fluorescence and high ROS productivity in the aggregated state, starkly contrasting the >90% quenching observed in conventional ACQ-type small molecules. This effective partial decoupling of optical functions and suppression of ACQ enable high-contrast NIR-II fluorescence imaging-guided combined phototherapy in vivo. Our work provides a general design paradigm based on copolymer modularity for developing high-performance quenching-resistant organic phototheranostics.


  • Open Access

    Planar rotor-enabled quenching-resistant NIR-II fluorophores for high-contrast bioimaging and efficient cancer phototheranostics

    by Weilong Chen, Sa Wang, Ganipisetti Hanumantha Rao, Ka-Wai Lee, Zhiqiang Guan, Siyu Chen, Yuqing Li, Chuang Zhang, Yeteng Zhong, Jinfeng Zhang, et al.

    A novel small-molecule fluorophore, BTP-2TCF, featuring planar tricyanofuran rotors, exhibits quenching-resistant NIR-II fluorescence and ROS generation. Its nanoparticles demonstrate superior in vivo phototheranostic efficacy.


  • Open Access

    Machine Learning Assisted Prediction of Degradation Behavior of Poly(Lactic‐Co‐Glycolic Acid)

    by Shuai Wang, Long Chen, Kepeng Yang, Bowen Cheng, Yingpeng Wan, Bingyan Wang, Tao Sun, Xiangping Hao, Jingzhi Yang, Haijun Zhang, et al.

    Poly(lactic‐co‐glycolic acid) (PLGA) is widely used in biomedical implants due to its excellent biocompatibility and nontoxic degradation by products. Accurately predicting its degradation is crucial for implant stability. Traditional hydrolytic and autocatalytic models offer valuable insights but have limitations in describing real‐world degradation kinetics. To address this problem, machine learning (ML) is applied to predict PLGA degradation under physiological conditions. Eight features, including molecular weight, lactide/glycolide ratio, pH, temperature, surface‐area‐to‐volume ratio, geometry shape, degradation time, and lactide stereochemistry type, were used to predict degradation behavior. A dataset with 484 data points from 30 studies trained six ML models: k‐nearest neighbors (KNN), random forest regression (RFR), eXtreme Gradient Boosting Regression (XGBR), AdaBoost regression (ABR), Cat Boosting regression (CBR), and gradient boosting regression (GBR). GBR was identified as the optimized model, with a determination coefficient of 0.90. SHapley Additive exPlanations (SHAP) analysis identified degradation time, molecular weight, and lactide/glycolide ratio as the most influential features. This study demonstrates the potential of ML in predicting PLGA degradation behavior, reducing the need for extensive lab tests and providing data support for accurate predictions of in vivo implant degradation.


  • Stable intermolecular charge-transfer nanocrystals as efficient immunogenic cell death adjuvants for photoimmunotherapy against trophoblastic and recurrent tumors

    by Yijian Gao, Zhongming Huang, Wenbin Chen, Yujie Ma, Xiliang Li, Yu Wang, Yingpeng Wan, Ying Liu, Yuliang Yang, Ming-De Li, et al.


  • High Sensitivity Photoacoustic Imaging by Learning From Noisy Data

    by Xu Tang, Jiangbo Chen, Zheng Qu, Jingyi Zhu, Mohammadreza Amjadian, Mingxuan Yang, Yingpeng Wan, Lidai Wang

    Photoacoustic imaging (PAI) is a high-resolution biomedical imaging technology for the non-invasive detection of a broad range of chromophores at multiple scales and depths. However, limited by low chromophore concentration, weak signals in deep tissue, or various noise, the signal-to-noise ratio of photoacoustic images may be compromised in many biomedical applications. Although improvements in hardware and computational methods have been made to address this problem, they have not been readily available due to either high costs or an inability to generalize across different datasets. Here, we present a self-supervised deep learning method to increase the signal-to-noise ratio of photoacoustic images using noisy data only. Because this method does not require expensive ground truth data for training, it can be easily implemented across scanning microscopic and computed tomographic data acquired with various photoacoustic imaging systems. In vivo results show that our method makes the vascular details that were completely submerged in noise become clearly visible, increases the signal-to-noise ratio by up to 12-fold, doubles the imaging depth, and enables high-contrast imaging of deep tumors. We believe this method can be readily applied to many preclinical and clinical applications.


  • Non‐Fused Conjugated Oligomer with Manipulated Intermolecular Charge Transfer for Highly Efficient Near‐Infrared Phototheranostics of Cancer

    by Ka‐Wai Lee, Chuang Zhang, Yu‐Chi You, Yingpeng Wan, Zhiqiang Guan, Ji‐Hua Tan, I‐Hsiang Wang, Jinfeng Zhang, Ken‐Tsung Wong, Chun‐Sing Lee

    Near‐infrared (NIR) phototheranostics, combining photoacoustic imaging (PAI) and photothermal therapy (PTT), show great promise for cancer diagnosis and treatment. Organic molecules are excellent photothermal agents (PTAs) due to their strong NIR absorption and biodegradability. Typically, achieving good NIR response involves using fused‐ring backbones, which require complex synthesis and yield lower production. In this work, 2F nanoparticles (NPs) are reported as an organic phototheranostic agent with high NIR responses, synthesized in just two simple steps with an 87% production yield for efficient PAI‐guided PTT of cancer. Unlike traditional fused‐ring structures, 2F is formed by joining donor and acceptor moieties with simple carbon–carbon bonds, simplifying synthesis and increasing yield. Although isolated 2F molecules have lower NIR absorption, forming NPs shifts the absorption peak from 708 to 808 nm, achieving NIR absorption comparable to state‐of‐the‐art phototheranostics. This shift is due to significant charge transfer between dimers, forming a single‐component charge‐transfer complex with improved NIR absorption, as shown by absorption spectra and theoretical studies. Finally, 2F NPs demonstrate successful PAI‐guided PTT of cancer under NIR excitation with strong anti‐tumor performance. This work provides valuable insight into achieving both high synthesis yield and excellent photophysical performance in PTAs, advancing the development of PTT.


  • Top Cited Papers

    Organic Optoelectronic Materials: A Rising Star of Bioimaging and Phototherapy

    by Ka‐Wai Lee, Yingpeng Wan, Zhongming Huang, Qi Zhao, Shengliang Li, Chun‐Sing Lee

    Recently, many organic optoelectronic materials (OOMs), especially those used in organic light‐emitting diodes (OLEDs), organic solar cells (OSCs), and organic field‐effect transistors (OFETs), are explored for biomedical applications including imaging and photoexcited therapies. In this review, recently developed OOMs for fluorescence imaging, photoacoustic imaging, photothermal therapy, and photodynamic therapy, are summarized. Relationships between their molecular structures, nanoaggregation structures, photophysical mechanisms, and properties for various biomedical applications are discussed. Mainly four kinds of OOMs are covered: thermally activated delayed fluorescence materials in OLEDs, conjugated small molecules and polymers in OSCs, and charge‐transfer complexes in OFETs. Based on the OOMs unique optical properties, including excitation light wavelength and exciton dynamics, they are respectively exploited for suitable biomedical applications. This review is intended to serve as a bridge between researchers in the area of organic optoelectronic devices and those in the area of biomedical applications. Moreover, it provides guidance for selecting or modifying OOMs for high‐performance biomedical uses. Current challenges and future perspectives of OOMs are also discussed with the hope of inspiring further development of OOMs for efficient biomedical applications.


  • Innovative probes with aggregation-induced emission characteristics for sensing gaseous signaling molecules

    by Ka-Wai Lee, Huan Chen, Yingpeng Wan, Zhen Zhang, Zhongming Huang, Shengliang Li, Chun-Sing Lee